| 000 | 01517 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516141212.0 | ||
| 264 | 0 | _c20140422 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1469-0705 | ||
| 024 | 7 |
_a10.1002/uog.12456 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Brien, J M | |
| 245 | 0 | 0 |
_aMedication safety is still an issue in obstetrics 50 years after the Kefauver-Harris amendments: the case of progestogens. _h[electronic resource] |
| 260 |
_bUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology _cSep 2013 |
||
| 300 |
_a247-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a17 alpha-Hydroxyprogesterone Caproate |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyprogesterones _xadverse effects |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 |
_aObstetrics _xmethods |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPremature Birth _xdrug therapy |
| 650 | 0 | 4 |
_aProgesterone Congeners _xadverse effects |
| 650 | 0 | 4 |
_aProgestins _xadverse effects |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology _gvol. 42 _gno. 3 _gp. 247-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/uog.12456 _zAvailable from publisher's website |
| 999 |
_c22584304 _d22584304 |
||